Hard to say. I love the concept. Information is king and providing a database for tested, registered strains and their uses could be huge. However, the lack of updates is worrisome and the share structure is bad. Leadership is key. Can Angel pull this off? I hope so. Most people here are long and long suffering but we still believe. Go Budgenius!
News 
Market Data 
Discover 
